| Similar Articles |
|---|
 |
U.S. CPSC
June 4, 2010 |
McDonald's Recalls Movie Themed Drinking Glasses Due to Potential Cadmium Risk The designs on the glasses contain cadmium. Long term exposure to cadmium can cause adverse health effects.   |
The Motley Fool
June 8, 2010
Alyce Lomax |
Keep the Faith in McDonald's A flight to quality should include the fast-food chain's shares. |
The Motley Fool
June 4, 2010
Rick Aristotle Munarriz |
You Want Cadmium With That Shake? McDonald's is recalling 12 million of its Shrek-themed glasses after the Consumer Product Safety Commission detected cadmium in the painted designs. |
The Motley Fool
April 27, 2009
Brian Orelli |
A Capitalist Pig's View of Swine Flu So you want to make money from the swine flu? Here's how to do so. |
Chemistry World
July 24, 2009
Matt Wilkinson |
Pharma's shot in the arm? As swine flu cases continue to erupt around the globe, the latest financial results from pharmaceutical companies Roche and GlaxoSmithKline reveal that sales of their antiviral drugs have soared. |
The Motley Fool
May 28, 2009
Brian Orelli |
How to Make a Stockpile in Your Portfolio The swine flu has turned out to be a relative dud, hasn't it? It hasn't done much but create a buying opportunity for those who didn't panic. Where should you look to profit from it now? |
| AskMen.com |
Drug-Resistant Swine Flu Surfaces Health officials have confirmed a case of swine flu that is resistant to Tamiflu, the leading pharmaceutical weapon against the new virus. |
The Motley Fool
February 4, 2010
Brian Orelli |
Glaxo Brings Home the Bacon Swine flu gives GlaxoSmithKline the boost, but how long will it last? |
Chemistry World
August 2010 |
Column: The crucible Did you hear about the McDonald's 'Shrekgate' fiasco? Colorful characters from the Shrek movies adorned drinking glasses being sold in the burger chain's US branches, but sadly the images had been painted with cadmium pigments. |
The Motley Fool
March 16, 2006
Rich Duprey |
Avian Flu Ruffling Feathers Roche Pharmaceuticals boosts anti-flu drug production to quiet calls for generics. While the situation bears watching for now, it's not necessarily something for investors to get their feathers ruffled about. |
The Motley Fool
September 16, 2009
Brian Orelli |
Here Come the Swine Flu Vaccines Drugmakers moved one step closer to getting swine flu vaccines into your arm with approvals by the Food and Drug Administration. |
The Motley Fool
April 19, 2006
John Bluis |
Gilead's Got Cash Up to the Gills The pharmaceutical cashes in on bird-flu fears. The company's strong performance means that investors have to pay a slight premium for its shares. |
AskMen.com
Jacob Franek |
Swine Flu Update With the fall flu season rapidly approaching, a swine flu update is warranted. |
The Motley Fool
November 29, 2007
Brian Lawler |
Another Chapter in Glaxo's Relenza Saga An FDA advisory panel suggested that the Relenza label should be strengthened to include the possibility of abnormal behavior and hallucinations in those who take it. |
Chemistry World
November 27, 2012
Andrew Turley |
Roche and the Tamiflu data The Swiss pharma company has agreed to talk to external groups about full access to data for antiviral Tamiflu (oseltamivir) tablets, according to a letter published by the British Medical Journal. |
The Motley Fool
June 2, 2010
Matt Koppenheffer |
Is BP a Buy? The clobbering that BP's stock has taken may have created an investment opportunity. |
The Motley Fool
December 18, 2009
Brian Orelli |
Swine Flu Just Isn't Bringing Home the Bacon Looks like that one-time boost from sales of swine flu vaccine may not add much to the bottom lines of vaccine makers like GlaxoSmithKline, AstraZeneca, sanofi-aventis, and Novartis. |
The Motley Fool
May 26, 2010
Todd Wenning |
Deep-Sea Danger: Is BP's Dividend Doomed? (Fool TV) Oil giant BP has been in the news a lot over the past month, and not for the best of reasons. |
The Motley Fool
June 18, 2010
Mac Greer |
The British Side of the Gulf Coast Oil Spill A chat with David Kuo of the Motley Fool UK about the BP oil spill. |
The Motley Fool
August 9, 2010
Mac Greer |
Fool Roundtable: BP's Uncapped Potential Motley Fool Money radio show talks about the future of BP. |
The Motley Fool
May 10, 2010
James Early |
Got Oil Stocks? Get Out of the Gulf! (Fool TV) The lead advisor of Motley Fool Income Investor believes that any oil and gas company drilling in the Gulf of Mexico should be girding for a sea change in its operations, and investors should take heed. He explains why in this video. |
| AskMen.com |
Swine Flu: The Game Dutch researchers have created a free, online-only game that challenges players to control a new pandemic -- swine flu. |
The Motley Fool
March 30, 2006
David Compton |
Glaxo's New Flu-Fighting Ammo The FDA certifies the drugmaker's Relenza for defense as well as offense. For investors seeking to give their portfolios a shot in the arm, now might be the time to take a closer look at Glaxo. |
The Motley Fool
July 9, 2010 |
The BP Stat That Will Shock You Just one month before its April 20 Gulf of Mexico oil spill, BP claimed it could skim 491,721 barrels of oil a day in the event of a major oil spill. The real number is closer to 900 barrels. |
Pharmaceutical Executive
December 1, 2005
Anthony Tao |
The Avian Few: Is it Too Late for Pharma to Re-enter the Vaccine Fray? Small profit margins and high litigation risks drove most companies out of the vaccine business decades ago. As a possible pandemic looms, pharma re-enters the fray. Is it too late? |
The Motley Fool
June 18, 2010
Claire Stephanic |
Motley Fool Wire: Top 3 Stories Read this week's selected stories from around the Web that alert us to news about gaming consoles, profiles about Tony Hayward, CEO of BP, and what Best Buy is doing to attract women shoppers. |
BusinessWeek
August 5, 2010
Fisk & Calkins |
BP: Now Come the Fines BP could face as much as $17.6 billion in civil penalties for Gulf spill, though the actual amount is likely to be much lower. |
The Motley Fool
October 17, 2005
Brian Gorman |
Chasing Down Bird Flu Sanofi and GlaxoSmithKline are emerging as the likely winners in the race to produce a bird flu vaccine. |
Chemistry World
December 15, 2009
Sarah Houlton |
Pharma's year of merger mania Away from the corporate world, the big pharma story of 2009 was the emergence of a new health scare - swine flu. |
AskMen.com
Jacob Franek |
Swine Flu: The Good, The Bad And The Ugly Here is a short list of what we do and don't know of swine flu. |
The Motley Fool
November 30, 2006
Brian Lawler |
Happy (Sniffle) Holidays (Cough) It's flu season again, and the market for influenza vaccines is hot. Pharma investors, take note. |
BusinessWeek
May 26, 2010
Reed et al. |
BP Faces Extra Obstacles After Spill Past safety lapses heighten skepticism of the oil giant |
The Motley Fool
March 7, 2006
Will Frankenhoff |
2 Ideas to Fuel Your Portfolio: Part 2 ExxonMobil and BP aren't exactly the sexiest stock stories, but they represent the cream of the crop and should be core holdings for long-term investors in the oil patch. |
The Motley Fool
April 29, 2010
Brian Orelli |
Earnings Up 17%, but Here's Why You Should Be Worried One-time sales are no way to run a pharmaceutical business. |
U.S. CPSC
January 29, 2010 |
FAF Inc. Recalls Children's Necklaces Sold Exclusively at Walmart Stores Due to High Levels of Cadmium The recalled necklaces contain high levels of cadmium. Cadmium is toxic if ingested by young children and can cause adverse health effects. |
The Motley Fool
April 5, 2011
Frank Vinluan |
GSK in Emerging Markets: Why Sales Staff There Are Key to Global Strategy GlaxoSmithKline's rivalry with top drug companies such as Pfizer goes beyond the products they sell. In some emerging markets, it now also extends to the staff they're fighting to keep. |
Chemistry World
January 22, 2015
Rebecca Trager |
BP Deepwater oil spill fines set to fall dramatically A US district court judge has ruled that BP spilled less oil into the Gulf of Mexico after the Deepwater Horizon oil rig explosion in April 2010 than the US government claimed. |
The Motley Fool
February 23, 2010
Brian Orelli |
The End of a Swine Flu Era A Food and Drug Administration advisory panel recommended yesterday that next year's seasonal flu vaccine contain the vaccine for the H1N1 virus, aka the swine flu. |
The Motley Fool
January 6, 2011
Owain Bennallack |
BP Is Attracting Interest Again As the blame spreads for last year's oil spill, BP is looking better. |
The Motley Fool
September 27, 2010
David Lee Smith |
Can Its First American CEO Save BP? Robert Dudley's reign is just beginning; can BP make it? |
Chemistry World
December 22, 2010
Sarah Houlton |
Fines, Flu and an Uncertain Future It was another tough year for the pharma industry, with downsizing, pricing concerns and the impending expiration of patents on many products. But some of the biggest headlines were caused by eye-watering fines dished out in the US. |
The Motley Fool
May 26, 2010
David Lee Smith |
Is Anything Going Right for BP? Once the revolting gulf oil spill finally ends, you might want to reexamine BP's stock. |
The Motley Fool
April 26, 2011
David Lee Smith |
BP's Cheap -- and Worth Your Attention With studies placing Macondo blame on its contractors, BP merits attention. |
The Motley Fool
July 22, 2009
Brian Orelli |
Grab Hold of This Growth Double-digit growth just keeps coming for Gilead Sciences. |
The Motley Fool
June 17, 2010
David Lee Smith |
The Outlook on the Gulf Spill Just Got Scarier With the Gulf oil spill now eight weeks old, hyperbole and silly ideas are beginning to surface. |
IndustryWeek
July 21, 2010 |
Too Lenient on BP? BP's blatant disregard for safety. |
BusinessWeek
June 3, 2010
Wechsler & Lauerman |
Entrepreneurs with 35,000 Ideas for BP Thousands of would-be saviors have responded to the call for fixing the spill, but few have made it into actual testing, frustrating entrepreneurs. |
Fast Company
October 2010
Anya Kamenetz |
Why Environmental Activists Embrace Social Media Six months after the BP oil spill, it's clear that in the age of social media, a company can't spin and rebrand its way out of a mess like it used to. |
